Zim moves into cannabis pharma production

ZIMBABWE’S medicinal cannabis industry is moving from cultivation to high-value pharmaceutical manufacturing, with a new processing facility in Headlands now producing Active Pharmaceutical Ingredients (APIs).

The plant, operated by Ivory Medical, marks a major step in local value addition as cannabis is refined into pharmaceutical-grade inputs, reducing dependence on raw material exports.

Ivory Medical quality control manager Fortune Chagonda said the facility was designed to meet strict international standards while building a structured domestic supply chain.

This story is for NewsDay subscribers.